Back to top
more

Elevance Health, Inc. (ELV)

(Delayed Data from NYSE)

$417.86 USD

417.86
1,931,027

+3.85 (0.93%)

Updated Nov 4, 2024 04:00 PM ET

After-Market: $417.84 -0.02 (0.00%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

5-Strong Sell of 5         5

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value B Growth C Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 40% (149 out of 250)

Industry: Medical Services

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Kaibalya Pravo Dey headshot

Is a Surprise Coming for Elevance (ELV) This Earnings Season?

by Kaibalya Pravo Dey

Elevance (ELV) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

Nalak Das headshot

5 Giants Likely to Win Big on Earnings Results This Week

by Nalak Das

We have narrowed our search to five large-cap stocks that are poised to beat on earnings results this week. These are: NFLX, ISRG, ELV, EFX, CSX.

Elevance Health (ELV), CD&R to Unveil Primary Care Offering

by Zacks Equity Research

Elevance Health (ELV) forms an alliance with CD&R to enhance primary care delivery by making collective use of the partners' assets and subsequently, reduce overall costs of care.

The Zacks Analyst Blog Highlights Microsoft, Novo Nordisk, United Parcel Service, Booking and Elevance Health

by Zacks Equity Research

Microsoft, Novo Nordisk, United Parcel Service, Booking and Elevance Health are included in this Analyst Blog.

Will Elevance (ELV) Beat Q1 Earnings on Carelon Strength?

by Zacks Equity Research

The first-quarter results of Elevance (ELV) are likely to reflect higher product revenues and Commercial Individual membership growth.

Sheraz Mian headshot

Top Analyst Reports for Microsoft, Novo Nordisk & United Parcel

by Sheraz Mian

Today's Research Daily features new research reports on 16 major stocks, including Microsoft Corporation (MSFT), Novo Nordisk A/S (NVO) and United Parcel Service, Inc. (UPS).

Medpace (MEDP) Earnings Expected to Grow: Should You Buy?

by Zacks Equity Research

Medpace (MEDP) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Elevance Health (ELV) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

by Zacks Equity Research

Elevance Health (ELV) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Elevance Health (ELV) Brand Inks Deal to Better Serve Georgia

by Zacks Equity Research

Elevance Health's (ELV) brand, Anthem Blue Cross and Blue Shield, collaborates to make the benefits of Piedmont's healthcare network available to its members across specific Georgia regions.

ELV vs. GDRX: Which Stock Is the Better Value Option?

by Zacks Equity Research

ELV vs. GDRX: Which Stock Is the Better Value Option?

Why Elevance Health (ELV) is Poised to Beat Earnings Estimates Again

by Zacks Equity Research

Elevance Health (ELV) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

How to Find Strong Medical Stocks Slated for Positive Earnings Surprises

by Zacks Equity Research

Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.

Nalak Das headshot

Wall Street Set to See a Broad-Based Rally in Q2: 5 Picks

by Nalak Das

It will be prudent to invest in non-technology stocks with a favorable Zacks Rank to gain in the near future. Five such stocks are: WELL, GIS, ELV, RCL, RYAAY.

Kaibalya Pravo Dey headshot

Health Insurance Stocks Drop: Insights Into the Late Monday Fall

by Kaibalya Pravo Dey

Higher costs and lower hikes in rates can lead to lower profit growth, which concerns investors.

Should You Invest in the iShares U.S. Healthcare Providers ETF (IHF)?

by Zacks Equity Research

Sector ETF report for IHF

Elevance Health (ELV) Dips More Than Broader Market: What You Should Know

by Zacks Equity Research

In the latest trading session, Elevance Health (ELV) closed at $513.85, marking a -0.16% move from the previous day.

ELV or GDRX: Which Is the Better Value Stock Right Now?

by Zacks Equity Research

ELV vs. GDRX: Which Stock Is the Better Value Option?

Humana (HUM), DUOS Unveil Program to Improve Veterans' Health

by Zacks Equity Research

Humana (HUM) collaborates with DUOS to develop a program that aims to provide personalized care and assure the well-being of Louisiana's Veteran community, who have a HUM MA plan and suffer from chronic conditions.

Sera Prognostics, Inc. (SERA) Reports Q4 Loss, Lags Revenue Estimates

by Zacks Equity Research

Sera Prognostics (SERA) delivered earnings and revenue surprises of 0% and 56.84%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?

HealthEquity (HQY) Q4 Earnings Surpass Estimates, Margins Up

by Zacks Equity Research

HealthEquity (HQY) witnesses solid growth in HSAs, besides recording robust performances in the majority of its segments, in the fourth quarter of fiscal 2024.

Derek Lewis headshot

3 Stocks to Buy for Decreased Volatility

by Derek Lewis

For those seeking a more conservative approach, low-beta stocks are common targets. Interestingly enough, analysts have recently become bullish on these three.

HealthEquity (HQY) Beats Q4 Earnings and Revenue Estimates

by Zacks Equity Research

HealthEquity (HQY) delivered earnings and revenue surprises of 12.50% and 1.48%, respectively, for the quarter ended January 2024. Do the numbers hold clues to what lies ahead for the stock?

Cencora (COR) Hits 52-Week High: What's Driving the Stock?

by Zacks Equity Research

Investors are optimistic about Cencora's (COR) strength in the U.S. Healthcare Solutions business.

Why Elevance (ELV) is a Smart Addition to Your Portfolio Now

by Zacks Equity Research

Elevance's (ELV) top line is poised to gain from rising product revenues, administrative fees and other revenues.

Elevance Health (ELV) Ascends While Market Falls: Some Facts to Note

by Zacks Equity Research

The latest trading day saw Elevance Health (ELV) settling at $510.57, representing a +0.21% change from its previous close.